These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21889464)

  • 1. A modified FCCS procedure applied to Ly49A-MHC class I cis-interaction studies in cell membranes.
    Strömqvist J; Johansson S; Xu L; Ohsugi Y; Andersson K; Muto H; Kinjo M; Höglund P; Widengren J
    Biophys J; 2011 Sep; 101(5):1257-69. PubMed ID: 21889464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.
    Chalifour A; Scarpellino L; Back J; Brodin P; Devèvre E; Gros F; Lévy F; Leclercq G; Höglund P; Beermann F; Held W
    Immunity; 2009 Mar; 30(3):337-47. PubMed ID: 19249231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis.
    Andersson KE; Williams GS; Davis DM; Höglund P
    Eur J Immunol; 2007 Feb; 37(2):516-27. PubMed ID: 17236237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.
    Choi T; Ferris ST; Matsumoto N; Poursine-Laurent J; Yokoyama WM
    J Immunol; 2011 Apr; 186(7):3911-7. PubMed ID: 21335486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic.
    Held W; Raulet DH
    Eur J Immunol; 1997 Nov; 27(11):2876-84. PubMed ID: 9394813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.
    Ma BJ; Craveiro Salvado CM; Kane KP
    Immunogenetics; 2014 Aug; 66(7-8):467-77. PubMed ID: 24797174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis.
    Scarpellino L; Oeschger F; Guillaume P; Coudert JD; Lévy F; Leclercq G; Held W
    J Immunol; 2007 Feb; 178(3):1277-84. PubMed ID: 17237373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction with H-2D(d) in cis is associated with a conformational change in the Ly49A NK cell receptor.
    Back J; Angelov GS; Mariuzza RA; Held W
    Front Immunol; 2011; 2():55. PubMed ID: 22566845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.
    Alvarez M; Sungur CM; Ames E; Anderson SK; Pomeroy C; Murphy WJ
    J Immunol; 2013 Jul; 191(2):688-98. PubMed ID: 23752612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MHC class I alleles on licensing of Ly49A+ NK cells.
    Jonsson AH; Yang L; Kim S; Taffner SM; Yokoyama WM
    J Immunol; 2010 Apr; 184(7):3424-32. PubMed ID: 20194719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
    Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
    J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.
    Andrews DM; Sullivan LC; Baschuk N; Chan CJ; Berry R; Cotterell CL; Lin J; Halse H; Watt SV; Poursine-Laurent J; Wang CR; Scalzo AA; Yokoyama WM; Rossjohn J; Brooks AG; Smyth MJ
    Nat Immunol; 2012 Dec; 13(12):1171-7. PubMed ID: 23142773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.
    Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P
    J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules.
    Tanamachi DM; Hanke T; Takizawa H; Jamieson AM; Raulet DR
    J Exp Med; 2001 Feb; 193(3):307-15. PubMed ID: 11157051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educated natural killer cells show dynamic movement of the activating receptor NKp46 and confinement of the inhibitory receptor Ly49A.
    Staaf E; Hedde PN; Bagawath Singh S; Piguet J; Gratton E; Johansson S
    Sci Signal; 2018 Feb; 11(517):. PubMed ID: 29440510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable dimerization of the Ly49A natural killer cell receptor results in differential engagement of its MHC class I ligand.
    Dam J; Baber J; Grishaev A; Malchiodi EL; Schuck P; Bax A; Mariuzza RA
    J Mol Biol; 2006 Sep; 362(1):102-13. PubMed ID: 16899255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells.
    Ganesan S; Höglund P
    Front Immunol; 2018; 9():3173. PubMed ID: 30693005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells.
    Chung DH; Natarajan K; Boyd LF; Tormo J; Mariuzza RA; Yokoyama WM; Margulies DH
    J Immunol; 2000 Dec; 165(12):6922-32. PubMed ID: 11120818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
    Held W; Kunz B
    Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.